Table 1 The clinicopathologic characteristics of the patients
Clinicopathologic factors | Number of patients (%) |
|---|---|
Histologic type | |
 Serous | 140 (56.5) |
 Mucinous | 47 (19.0) |
 Endometrioid | 19 (7.7) |
 Clear | 42 (16.9) |
Residual tumor | |
 Optimal | 167 (90.8) |
 Suboptimal | 17 (9.2) |
Tumor grade | |
 1 | 57 (23.0) |
 2 | 122 (49.2) |
 3 | 69 (27.8) |
Tumor stage | |
 Early | 68 (37.2) |
 Advanced | 115 (62.8) |
Nuclear grade | |
 Mild and moderate | 137 (55.2) |
 Marked | 111 (44.8) |
Mitosis | |
 0–9/10 HPFs | 93 (37.5) |
 10–24/10 HPFs | 95 (38.3) |
 > =25/10 HPFs | 60 (24.2) |
Chemoresponse | |
 Regressive disease | 73 (43.5) |
 Stable/progressive disease | 95 (56.5) |